1-substituted 4-arylpiperazine as kappa opioid receptor antagonists
Provided are compounds represented by the formula: where R, Y 3 , R 1 , R 2 , R 3 , R 4 , R 6 , G, R 7 , E 1 , E 2 , A, B, W, X, Y and Z are as defined herein.
1. A compound represented by the formula:
wherein
W, X, Y and Z are, independently, hydrogen, C 1-3 alkyl, OC 1-3 alkyl, F, OH, Br, Cl, CN, CF 3 , NO 2 , SO 2 CH 3 , SO 2 CF 3 or SO 2 NH 2 .
2. The compound of claim 1 , wherein W, X, Y and Z are, independently, hydrogen, methyl, methoxy, F, Cl or OH.
3. The compound of claim 1 , wherein W, V, X, Y and Z are, independently, hydrogen, methyl, Cl or OH.
4. The compound of claim 1 , wherein W is hydrogen, methyl or Cl.
5. The compound of claim 1 , wherein X is hydrogen, methoxy or OH.
6. The compound of claim 1 , wherein Y is hydrogen, methyl or methoxy.
7. The compound of claim 1 , wherein Z is hydrogen, F, methyl or methoxy.
8. The compound of claim 1 , which is represented by the formula:
9. The compound of claim 1 , which is represented by the formula:
10. The compound of claim 1 , which is a pharmaceutically acceptable salt.
11. A pharmaceutical composition, comprising the compound of claim 1 and a pharmaceutically acceptable carrier.